A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Apr 2018

At a glance

  • Drugs LYC 30937 (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Acronyms UPSTART
  • Sponsors Lycera
  • Most Recent Events

    • 13 Apr 2018 This trial has been completed in Netherlands (end date: 2018-03-26)
    • 06 Apr 2018 This trial has been completed in Hungary (end date: 2018-03-28)
    • 21 Dec 2017 Planned End Date changed from 1 Jan 2018 to 1 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top